Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of TAK-783, once daily
(QD), taken in combination with methotrexate in subjects with rheumatoid arthritis.